AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $19.9B
- YoY, 2025
- −0.2%
- 5-year CAGR
- +12.0%
- 10-year CAGR
- +6.0%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $19.9B | −0.2% |
| 2024 | $20.0B | +4.0% |
| 2023 | $19.2B | +4.3% |
| 2022 | $18.4B | +20.9% |
| 2021 | $15.2B | +34.9% |
| 2020 | $11.3B | −3.3% |
| 2019 | $11.7B | +16.5% |
| 2018 | $10.0B | −2.0% |
| 2017 | $10.2B | +8.7% |
| 2016 | $9.4B | −15.3% |
| 2015 | $11.1B | — |